Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fine Success Investments Limited is a private investment holding company based in the British Virgin Islands that serves as a primary vehicle for the equity interests of Dr. Ge Li, the founder and chairman of the WuXi AppTec group. The company is a significant shareholder in both WuXi AppTec and WuXi Biologics, which are among the world's largest contract research, development, and manufacturing organizations (CRDMOs). While Fine Success does not engage in direct laboratory research or drug development, its strategic importance lies in its role within the corporate governance and ownership structure of the WuXi ecosystem. It is frequently cited in regulatory filings as a controlling or major shareholder of these global life sciences service providers. Consequently, the company's value and business activities are inextricably linked to the performance of the broader pharmaceutical services and biotechnology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fine Success Investments.